News on Symbollon Corporation from BioPortfolio.com http://www.BioPortfolio.com Consolidated Symbollon Corporation news from BioPortfolio.com Wed, 10 Feb 2010 04:30:33 GMT en Symbollon Pharmaceuticals Inc agreed to acquire New Zealand Pure Inchttp://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=4026406&HITNO=0&MSIZE=19&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=Symbollon%20Corporation&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=4026406&THISHREF=http://c.moreover.com/click/here.pl%3fz2530807096%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comhttp://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=4026406&HITNO=0&MSIZE=19&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=Symbollon%20Corporation&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=4026406&THISHREF=http://c.moreover.com/click/here.pl%3fz2530807096%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comMergerstat: The Sylk(R) Health and Personal Care Product Line to Be Acquired by Symbollonhttp://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=4013608&HITNO=1&MSIZE=19&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=Symbollon%20Corporation&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=4013608&THISHREF=http://c.moreover.com/click/here.pl%3fz2523775409%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comhttp://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=4013608&HITNO=1&MSIZE=19&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=Symbollon%20Corporation&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=4013608&THISHREF=http://c.moreover.com/click/here.pl%3fz2523775409%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comGenetic Engineering News: Symbollon Pharmaceuticals Inc-Therapeutic Competitors - new market report releasedhttp://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=4011370&HITNO=2&MSIZE=19&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=Symbollon%20Corporation&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=4011370&THISHREF=http://c.moreover.com/click/here.pl%3fz2522895180%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comhttp://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=4011370&HITNO=2&MSIZE=19&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=Symbollon%20Corporation&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=4011370&THISHREF=http://c.moreover.com/click/here.pl%3fz2522895180%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comPR inside: Symbollon Pharmaceuticals Inc-Detailed Product Pipeline - new market report releasedhttp://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=3995306&HITNO=3&MSIZE=19&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=Symbollon%20Corporation&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=3995306&THISHREF=http://c.moreover.com/click/here.pl%3fz2515591278%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comhttp://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=3995306&HITNO=3&MSIZE=19&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=Symbollon%20Corporation&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=3995306&THISHREF=http://c.moreover.com/click/here.pl%3fz2515591278%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comPR inside: Symbollon To Make IoGen Available In Februaryhttp://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=3948285&HITNO=4&MSIZE=19&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=Symbollon%20Corporation&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=3948285&THISHREF=http://c.moreover.com/click/here.pl%3fz2488498828%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comhttp://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=3948285&HITNO=4&MSIZE=19&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=Symbollon%20Corporation&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=3948285&THISHREF=http://c.moreover.com/click/here.pl%3fz2488498828%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comPharmaceutical Business Review: Woman's Breast Health Supplement, IoGen(TM), Available to Public in February From Symbollon Pharmaceuticalshttp://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=3941631&HITNO=5&MSIZE=19&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=Symbollon%20Corporation&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=3941631&THISHREF=http://c.moreover.com/click/here.pl%3fz2485518991%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comhttp://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=3941631&HITNO=5&MSIZE=19&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=Symbollon%20Corporation&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=3941631&THISHREF=http://c.moreover.com/click/here.pl%3fz2485518991%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comMarket Wire: Symbollon Pharmaceuticals, Inc.: Woman's Breast Health Supplement, IoGen(TM), Available to Public in February From Symbollon Pharmaceuticalshttp://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=3942370&HITNO=6&MSIZE=19&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=Symbollon%20Corporation&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=3942370&THISHREF=http://c.moreover.com/click/here.pl%3fz2485741550%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comhttp://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=3942370&HITNO=6&MSIZE=19&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=Symbollon%20Corporation&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=3942370&THISHREF=http://c.moreover.com/click/here.pl%3fz2485741550%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comMarket Wire: Woman's Breast Health Supplement, IoGen(TM), Available to Public in February From Symbollon Pharmaceuticalshttp://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=3941674&HITNO=7&MSIZE=19&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=Symbollon%20Corporation&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=3941674&THISHREF=http://c.moreover.com/click/here.pl%3fz2485546270%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comhttp://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=3941674&HITNO=7&MSIZE=19&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=Symbollon%20Corporation&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=3941674&THISHREF=http://c.moreover.com/click/here.pl%3fz2485546270%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comMarketwire via Yahoo!: Woman's Breast Health Supplement, IoGen(TM), Available to Public in February From Symbollon Pharmaceuticalshttp://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=3941725&HITNO=8&MSIZE=19&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=Symbollon%20Corporation&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=3941725&THISHREF=http://c.moreover.com/click/here.pl%3fz2485561522%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comhttp://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=3941725&HITNO=8&MSIZE=19&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=Symbollon%20Corporation&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=3941725&THISHREF=http://c.moreover.com/click/here.pl%3fz2485561522%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comPR inside: Woman's Breast Health Supplement, IoGen(TM), Available to Public in February From Symbollon Pharmaceuticalshttp://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=3941670&HITNO=9&MSIZE=19&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=Symbollon%20Corporation&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=3941670&THISHREF=http://c.moreover.com/click/here.pl%3fz2485545193%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comhttp://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=3941670&HITNO=9&MSIZE=19&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=Symbollon%20Corporation&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=3941670&THISHREF=http://c.moreover.com/click/here.pl%3fz2485545193%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comYahoo! Canada: Symbollon Pharmaceuticals to launch IoGen women's breast health dietary supplement in Februaryhttp://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=3942267&HITNO=10&MSIZE=19&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=Symbollon%20Corporation&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=3942267&THISHREF=http://c.moreover.com/click/here.pl%3fz2485721752%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comhttp://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=3942267&HITNO=10&MSIZE=19&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=Symbollon%20Corporation&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=3942267&THISHREF=http://c.moreover.com/click/here.pl%3fz2485721752%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comNews-Medical.Net: News and FDA Updates for Symbollon (OTC:SYMBA), Synta (NASDAQ:SNTA), Thermo Fisher (NYSE:TMO)http://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=3938628&HITNO=11&MSIZE=19&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=Symbollon%20Corporation&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=3938628&THISHREF=http://c.moreover.com/click/here.pl%3fz2484106883%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comhttp://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=3938628&HITNO=11&MSIZE=19&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=Symbollon%20Corporation&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=3938628&THISHREF=http://c.moreover.com/click/here.pl%3fz2484106883%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comLos Angeles Chronicle: Woman's Breast Health Supplement, IoGen(TM), Available to Public in February From Symbollon Pharmaceuticalshttp://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=3942486&HITNO=12&MSIZE=19&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=Symbollon%20Corporation&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=3942486&THISHREF=http://c.moreover.com/click/here.pl%3fz2485762372%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comhttp://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=3942486&HITNO=12&MSIZE=19&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=Symbollon%20Corporation&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=3942486&THISHREF=http://c.moreover.com/click/here.pl%3fz2485762372%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comIndividual.com: BiomedReports: News and FDA Updates for Symbollon (OTC:SYMBA), Synta (NASDAQ:SNTA), Thermo Fisher (NYSE:TMO)http://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=3935714&HITNO=13&MSIZE=19&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=Symbollon%20Corporation&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=3935714&THISHREF=http://c.moreover.com/click/here.pl%3fz2482711906%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comhttp://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=3935714&HITNO=13&MSIZE=19&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=Symbollon%20Corporation&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=3935714&THISHREF=http://c.moreover.com/click/here.pl%3fz2482711906%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comIndividual.com: Symbollon Retains Atech Solutions to Enhance Web Presence and Build Retail Site for the Sales of IoGenhttp://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=3929740&HITNO=14&MSIZE=19&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=Symbollon%20Corporation&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=3929740&THISHREF=http://c.moreover.com/click/here.pl%3fz2479746268%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comhttp://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=3929740&HITNO=14&MSIZE=19&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=Symbollon%20Corporation&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=3929740&THISHREF=http://c.moreover.com/click/here.pl%3fz2479746268%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comYahoo! Canada: